A complex genetic condition, Prader-Willi syndrome (PWS) is a result of the loss of the functioning of genes in a particular region of chromosome 15. Genetic testing confirms the definitive diagnosis of the condition.
The hallmark of PWS is a constant sense of hunger and obesity, and it affects approximately 1 out of every 15,000 births and has standard treatment.
The newsletter by DelveInsight offers a brief overview of the indication, its subtypes, and its symptoms. It focuses on the epidemiological trends segmented into geographies in the 7MM, ethnicity, gender, total, and diagnosed cases.
The newsletter focuses on its clients and readers, helping them gain insights into market trends and the pipeline therapies that shall veer the PWS market in a positive direction.
For rich insights into the Prader-Willi syndrome market landscape, fill the form and get the newsletter right into your virtual mailbox.
Embrace the hassle-free way of staying updated by subscribing to our emailer's list. Catch up with all the updates and trends in the Life Science industry in your inbox .
Know more about What's covered:
- Indication overview
- Epidemiological trends
- Treatment approaches
- Key Companies
- Pipeline drugs
- Support from International organizations
- Top conferences
- R&D in the field
- Collaborations and deals in the domain